Suppr超能文献

中介复合物亚基 13 在心脏疾病中的潜在作用。

Potential roles of mediator Complex Subunit 13 in Cardiac Diseases.

机构信息

The Center of Cardiovascular Diseases, the First Hospital of Jilin University, Changchun 130021, China.

Pediatric Research Institute, the Department of Pediatrics of University of Louisville, Louisville, KY 40202, USA.

出版信息

Int J Biol Sci. 2021 Jan 1;17(1):328-338. doi: 10.7150/ijbs.52290. eCollection 2021.

Abstract

Mediator complex subunit 13 (MED13, previously known as THRAP1 and TRAP240) is a subunit of the cyclin-dependent kinase 8 (CDK8) kinase module in the eukaryotic mediator complex. MED13 has been known to play critical roles in cell cycle, development, and growth. The purpose of this review is to comprehensively discuss its newly identified potential roles in myocardial energy metabolism and non-metabolic cardiovascular diseases. Evidence indicates that cardiac MED13 mainly participates in the regulation of nuclear receptor signaling, which drives the transcription of genes involved in modulating cardiac and systemic energy homeostasis. MED13 is also associated with several pathological conditions, such as metabolic syndrome and thyroid disease-associated heart failure. Therefore, MED13 constitutes a potential therapeutic target for the regulation of metabolic disorders and other cardiovascular diseases.

摘要

中介复合物亚基 13(MED13,以前称为 THRAP1 和 TRAP240)是真核中介复合物中环依赖性激酶 8(CDK8)激酶模块的一个亚基。MED13 已知在细胞周期、发育和生长中发挥关键作用。本综述的目的是全面讨论其在心肌能量代谢和非代谢性心血管疾病中新确定的潜在作用。有证据表明,心脏 MED13 主要参与核受体信号的调节,从而驱动调节心脏和全身能量稳态的基因的转录。MED13 还与几种病理状况有关,如代谢综合征和甲状腺疾病相关的心衰。因此,MED13 构成了调节代谢紊乱和其他心血管疾病的潜在治疗靶点。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/14d3/7757031/3431a171233f/ijbsv17p0328g001.jpg

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验